Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Shakespeare PG, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560–71.
Ogawa R, Akita S, Akaishi S, Aramaki-Hattori N, Dohi T, Hayashi T, et al. Diagnosis and treatment of keloids and hypertrophic scars-Japan scar workshop consensus document 2018. Burns Trauma. 2019;7:39.
Article PubMed PubMed Central Google Scholar
Wang CJ, Ko JY, Chou WY, Cheng JH, Kuo YR. Extracorporeal shockwave therapy for treatment of keloid scars. Wound Repair Regen. 2018;26:69–76.
Kaushal V, Kumar S, Brar BK, Singh A. Comparative evaluation of therapeutic efficacy and safety of intralesional triamcinolone acetonide injection vs intralesional radiofrequency with intralesional triamcinolone acetonide in treatment of keloids. Dermatol Ther. 2020;33: e13919.
Article CAS PubMed Google Scholar
Yin Q, Louter JMI, Niessen FB, Gibbs S, Tasdemir-Kilic G, Lapid O, et al. Intralesional corticosteroid administration in the treatment of keloids: a scoping review on injection methods. Dermatology. 2023.
Yin Q, Niessen FB, Gibbs S, Lapid O, Louter JMI, van Zuijlen PPM, Wolkerstorfer A. Intralesional corticosteroid administration in the treatment of keloids: a survey among Dutch dermatologists and plastic surgeons. J Dermatolog Treat. 2023;34:2159308.
Diamond IR, Grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM, Wales PW. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67:401–9.
Wang X, Wu X, Liu K, Xia L, Lin X, Liu W, Gao Z. Topical cryoanesthesia for the relief of pain caused by steroid injections used to treat hypertrophic scars and keloids. Medicine (Baltimore). 2017;96: e8353.
Jongkajornpong N WK. The efficacy of skin cooling for pain relief during intralesional steroid injection for keloid treatment: a randomized cross-over study. J Med Assoc Thailand. 2021:1752–7.
Limandjaja GC, van den Broek LJ, Waaijman T, van Veen HA, Everts V, Monstrey S, et al. Increased epidermal thickness and abnormal epidermal differentiation in keloid scars. Br J Dermatol. 2017;176:116–26.
Article CAS PubMed Google Scholar
Jiao H, Zhang T, Fan J, Xiao R. The superficial dermis may initiate keloid formation: histological analysis of the keloid dermis at different depths. Front Physiol. 2017;8:885.
Article PubMed PubMed Central Google Scholar
Syed F, Ahmadi E, Iqbal SA, Singh S, McGrouther DA, Bayat A. Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: clinical implications for lesional site-directed therapy. Br J Dermatol. 2011;164:83–96.
Article CAS PubMed Google Scholar
Simpson RC, Kirtschig G, Selk A, von Seitzberg S, Vittrup G, Bissonnette I, et al. Core outcome domains for lichen sclerosus: a CORALS initiative consensus statement. Br J Dermatol. 2023;188:628–35.
Young AM, Chung H, Chaplain A, Lowe JR, Wallace SJ. Development of a minimum dataset for subacute rehabilitation: a three-round e-Delphi consensus study. BMJ Open. 2022;12: e058725.
Article PubMed PubMed Central Google Scholar
Mirmovich O, Gil T, Goldin I, Lavi I, Mettanes I, Har-Shai Y. Pain evaluation and control during and following the treatment of hypertrophic scars and keloids by contact and intralesional cryosurgery—a preliminary study. J Eur Acad Dermatol Venereol. 2012;26:440–7.
Article CAS PubMed Google Scholar
Searle T, Ali FR, Al-Niaimi F. The role of pharmacogenetics in keloid scar treatment: a literature review. Scars Burn Heal. 2020;6:2059513120941704.
Article PubMed PubMed Central Google Scholar
Furtado F, Hochman B, Ferrara SF, Dini GM, Nunes JM, Juliano Y, Ferreira LM. What factors affect the quality of life of patients with keloids? Rev Assoc Med Bras. 1992;2009(55):700–4.
Bijlard E, Kouwenberg CA, Timman R, Hovius SE, Busschbach JJ, Mureau MA. Burden of keloid disease: a cross-sectional health-related quality of life assessment. Acta Derm Venereol. 2017;97:225–9.
Bari H. A prolonged release parenteral drug delivery system—an overview. Int J Pharm Sci Rev Res. 2010;3:1–11.
Benzon HT, Chew TL, McCarthy RJ, Benzon HA, Walega DR. Comparison of the particle sizes of different steroids and the effect of dilution: a review of the relative neurotoxicities of the steroids. Anesthesiology. 2007;106:331–8.
Article CAS PubMed Google Scholar
Firooz A, Tehranchi-Nia Z, Ahmed AR. Benefits and risks of intralesional corticosteroid injection in the treatment of dermatological diseases. Clin Exp Dermatol. 1995;20:363–70.
Article CAS PubMed Google Scholar
MacMahon PJ, Shelly MJ, Scholz D, Eustace SJ, Kavanagh EC. Injectable corticosteroid preparations: an embolic risk assessment by static and dynamic microscopic analysis. AJNR Am J Neuroradiol. 2011;32:1830–5.
Article CAS PubMed PubMed Central Google Scholar
Tiso RL, Cutler T, Catania JA, Whalen K. Adverse central nervous system sequelae after selective transforaminal block: the role of corticosteroids. Spine J. 2004;4:468–74.
Kahn CB, Hollander JL, Schumacher HR. Corticosteroid crystals in synovial fluid. JAMA. 1970;211:807–9.
Article CAS PubMed Google Scholar
Woliansky J, Phyland D, Paddle P. Systemic safety of serial intralesional steroid injection for subglottic stenosis. Laryngoscope. 2019;129:1634–9.
Article CAS PubMed Google Scholar
Cevc G, Blume G. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers. Transfersomes Biochim Biophys Acta. 2003;1614:156–64.
Article CAS PubMed Google Scholar
Spitzer MS, Kaczmarek RT, Yoeruek E, Petermeier K, Wong D, Heimann H, et al. The distribution, release kinetics, and biocompatibility of triamcinolone injected and dispersed in silicone oil. Invest Ophthalmol Vis Sci. 2009;50:2337–43.
Fernandes-Cunha GM, Saliba JB, Siqueira RC, Jorge R, Silva-Cunha A. Determination of triamcinolone acetonide in silicone oil and aqueous humor of vitrectomized rabbits’ eyes: application for a pharmacokinetic study with intravitreal triamcinolone acetonide injections (Kenalog® 40). J Pharm Biomed Anal. 2014;89:24–7.
Article CAS PubMed Google Scholar
Li J, Lee K, Chang D, Boominathan P, Banack T. A breast cancer survivor’s self-controlled case report: methylprednisolone acetate provided a week longer analgesia than dexamethasone sodium phosphate via thoracic paravertebral blockade. Cureus. 2019;11: e6085.
PubMed PubMed Central Google Scholar
Jobe AH, Milad MA, Peppard T, Jusko WJ. Pharmacokinetics and pharmacodynamics of intramuscular and oral betamethasone and dexamethasone in reproductive age women in India. Clin Transl Sci. 2020;13:391–9.
Article CAS PubMed Google Scholar
SmPC KenaCort. https://www.geneesmiddeleninformatiebank.nl/smpc/h05341_smpc.pdf.
Jarratt MT, Spark RF, Arndt KA. The effects of intradermal steroids on the pituitary-adrenal axis and the skin. J Invest Dermatol. 1974;62:463–6.
Article CAS PubMed Google Scholar
Zaynoun ST, Salti IS. The effect of intracutaneous glucocorticoids on plasma cortisol levels. Br J Dermatol. 1973;88:151–6.
Article CAS PubMed Google Scholar
Mcgugan AD, Shuster S, Bottoms E. Adrenal suppression from intradermal triamcinolone. J Invest Dermatol. 1963;40:271–2.
Samtani MN, Lohle M, Grant A, Nathanielsz PW, Jusko WJ. Betamethasone pharmacokinetics after two prodrug formulations in sheep: implications for antenatal corticosteroid use. Drug Metab Dispos. 2005;33:1124–30.
Comments (0)